Migraines cut by combined therapy, study shows

The use of beta blockers with behavioural management can improve migraine care, US research shows.

A team from Ohio University found that, compared to either method alone, the two interventions taken together were more effective at reducing severity and number of migraines.

The researchers assessed 232 adults with at least three migraines with disability every 30 days.

They examined the effects of four treatment combinations: beta blocker, placebo, behavioural migraine management plus beta blocker, or management plus placebo.

Patients were assessed for number of migraines per 30 days, and for change in quality of life as a result.

The researchers found that beta blocker plus management combination led to 3.3 fewer migraines per 30 days compared with optimised acute treatment alone.

However, the individual interventions or placebo alone provided no additional benefit over acute treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus